Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis
Open Access
- 2 February 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (3) , 1199
Abstract
Oxidative stress is known to be associated with the pathophysiology of chronic kidney disease (CKD). Paraoxonase 1 (PON1) is an antioxidant enzyme that has been proposed as a biomarker for CKD. While several studies have reported an association between serum PON1 activity and CKD, consensus based on systematically analyzed data remains necessary. We set out to conduct a meta-analysis of literature on PON1 in CKD. Electronic databases, such as MEDLINE, Embase and CENTRAL, were searched for available studies on PON1 activity in patients with CKD (without dialysis) as published before December 2022. A random-effects meta-analysis was performed. In total, 24 studies (22 studies on paraoxonase and 11 on arylesterase activity) were eligibly identified. Patients with CKD showed a lower activity of paraoxonase (standard mean difference [SMD], −1.72; 95% confidence interval [CI], −2.15 to −1.29) and arylesterase (SMD, −2.60; 95%CI, −3.96 to −1.24) than healthy controls. In the subgroup analyses, paraoxonase activity was lower in chronic kidney failure (CKF), an advanced stage of CKD, than in non-CKF. In summary, PON1 activity is low in patients with CKD, suggesting that the antioxidant defense by PON1 is impaired in CKD. The decrease in enzyme activity is pronounced in advanced CKD showing some variability depending on the substrate employed to measure PON1 activity. Further studies are warranted.Keywords
This publication has 55 references indexed in Scilit:
- Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Chronic Kidney DiseaseJournal of the American Heart Association, 2013
- Paraoxonase activity in healthy, diabetic, and hemodialysis patientsClinical Biochemistry, 2012
- Paraoxonase 1 in Chronic Kidney FailureJournal of Lipids, 2012
- Estimation of Oxidative Stress Markers in Chronic Kidney DiseaseKidney and Blood Pressure Research, 2010
- Serum paraoxonase activity in patients with low glomerular filtration ratesRenal Failure, 2010
- Discordance in Human Paraoxonase-1 Gene between Phenotypes and Genotypes in Chronic Kidney DiseaseNephron Clinical Practice, 2009
- The paraoxonases: role in human diseases and methodological difficulties in measurementCritical Reviews in Clinical Laboratory Sciences, 2009
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular RiskJAMA, 2008
- Serum paraoxonase activity and protein thiols in chronic renal failure patientsIndian Journal of Nephrology, 2008
- Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysisClinical Nephrology, 2007